Current Roles

Employees:
154
Revenue:
$38.7M
About
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading Magellan® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system.
Isto Biologics (Formerly Arteriocyte) Address
45 South Street
Hopkinton, MA
United States
Isto Biologics (Formerly Arteriocyte) Email
Isto Biologics (Formerly Arteriocyte) Phone Numbers
+18887054786

Past Companies

ISTO TechnologiesController

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.